OpenAI’s meteoric rise is fuelling Microsoft and Nvidia while casting a long shadow over Google’s search dominance. UBS warns the AI trade hinges on OpenAI’s growth – a boom for investors if it ...

Stock market rally hits 6600; learn the key support level to watch as Fed policy and weak data could trigger a short-term dip ...

We believe CrowdStrike Holdings Inc. has re-established growth momentum while still working through the financial and reputational overhang of the July 19, 2024 global outage. The company recently ...

Vertex Pharmaceuticals is backed by CF dominance and JOURNAVX optionality, with key catalysts ahead for growth and upside.

Trump’s tariffs continue to affect the global economy. Follow along for live updates on the Dow, S&P 500, Nasdaq and other markets.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

A Fed rate cut could give the People’s Bank of China (PBOC) room to ease policy without risking capital flight or yuan ...

A number of stocks jumped in the afternoon session after the latest Consumer Price Index (CPI) report came in largely as ...

Zapier reports that AI automation enhances traditional automation by combining intelligent technologies, improving efficiency ...

Klarna’s shares made a fast start following the BNPL company’s New York debut, but momentum waned later on. Should you invest ...

Learn more about whether Alvotech or Travere Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, ...

Learn more about whether ADMA Biologics, Inc. or Travere Therapeutics, Inc. is a better investment based on AAII's A+ ...